• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

T2J:GR

0.044 EUR 0.005 12.82%

As of 02:08:14 ET on 12/19/2014.

Snapshot for Taihua PLC (T2J)

Open: 0.044 Day's Range: 0.044 - 0.044 Volume: 0
Previous Close: 0.039 52wk Range: 0.024 - 0.050 1-Yr Rtn: +18.92%

Stock Chart for T2J

No chart data available.
  • T2J:GR 0.044
  • 1M
  • 1Y
0.039
Interactive T2J Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for T2J

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 3.60
Shares Outstanding (M) 81.74
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (GBp) 0.2500
Dividend Ex-Date 06/27/2008
5 Year Dividend Growth -
Next Earnings Announcement 06/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for T2J

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for T2J

Taihua PLC, through subsidiaries, produces active pharmaceutical ingredients. The Company produces paclitaxel and homoharringtonine, which it sells to drug manufacturers for use in anti-cancer medicines.

Yunwu LiuChief Executive OfficerLiyi ChenExecutive Director
Chun ChaiExecutive Director/Vice Gen Mgr
More Company Profile & Key Executives for T2J

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil